| Molecular Cardiology Research Institute |
| Staff Directory |
| Principal Investigators |
|
Alcaide, Pilar |
|
Beasley, Debbie |
|
Beinborn, Martin |
|
Blanton, Robert |
|
Cox, Daniel |
|
Draper, Isabelle |
|
Galper, Jonas |
|
Huggins, Gordon |
|
Iacomini, John |
|
Iyer, Lakshmanan |
|
Jaffe, Iris |
|
Karas, Richard |
| Kapur, Navin |
|
Kopin, Alan |
|
Kyriakis, John |
|
Lem, Janis |
|
Mendelsohn, Michael |
|
Park, Ho-Jin |
|
Schnitzler, Gavin |
 |
|
|
 |
Navin Kapur, M.D.
|
|
|
Navin Kumar Kapur is an Assistant Professor of Medicine at Tufts University School of Medicine and a staff member of the Division of Cardiology at Tufts Medical Center. Dr. Kapur received his M.D. from Georgetown University in Washington D.C. He completed training as a medical resident at Beth Israel Deaconess Medical Center followed by fellowships in Adult Cardiology, Heart Failure, and Interventional Cardiology at Johns Hopkins Hospital in Baltimore, MD. As part of an NIH Training Grant directed by Dr. David Kass, Dr. Kapur completed his postdoctoral research training in the laboratory of Dr. Jeffrey Rade at Johns Hopkins. During this time, Dr. Kapur explored the paracrine effects of transforming growth factor-beta (TGFb) on endocardial thromboresistance in heart failure.
The Kapur laboratory is studying the role of endoglin, a TGFb co-receptor, in cardiac fibrosis. The lab uses molecular approaches to study endoglin’s effect on extracellular matrix synthesis in human cardiac fibroblasts and employs animal models to study the role of endoglin in heart failure and myocardial infarction. As an interventional cardiologist, Dr. Kapur has several clinical studies evaluating the role of soluble endoglin in heart failure and acute myocardial infarction.
Research Administrator: Patricia Griffiths-Rossiter
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|